
After years of reports and debate about the extent to which cholesterol-lowering meds can lead to memory loss, the FDA has asked drugmakers to add information about ‘non-serious’ cognitive side effects to warning labels. At the same time, information is also being added about the possibility that statins can lead to diabetes, citing studies showing [...]